According to IQVIA, the branded product and its equivalents had total U.S. sales of $10 million for the twelve months ending September 2025.
RSV is a leading cause of infant hospitalizations in Canada, with older people and those who are immunocompromised also at greater risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback